ARCHIVES

Genentech: ODAC Lacks Expertise, Impartiality; FDA: Company’s Proposal Unscientific

This article is from The Cancer Letter archive.

Vol. 37 No. 32 | August 12, 2011

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 2 Issue 4, Fall 1988

September 13, 1988

In Brief: Moloney, Manaher, 11 Other NCI Staff Members Retire; Terry Takes Leave From Immunology Jobs

March 7, 1980

Clinical Trials Approved By NCI CTEP Last Month

March 25, 2011

SEER Program Challenged, Will Face Review

May 9, 1980

In Brief: President Asks $700 Million for NCI In 1977; Appropriation Delay Halts New Research Funds

January 2, 1976

Resource Offered for DNA Probe Mapping

August 14, 1987